Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5816643 | Phytomedicine | 2014 | 7 Pages |
Abstract
Based on these results, we propose that Myricanol elicits growth inhibitory and cytotoxic effects on lung cancer cells. Therefore, Myricanol may be a clinical candidate for the prevention and treatment of lung cancer.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Clinical Biochemistry
Authors
G.H. Dai, G.M. Meng, Y.L. Tong, X. Chen, Z.M. Ren, K. Wang, F. Yang,